Anderson localization on the Bethe lattice: nonergodicity of extended States.

Phys Rev Lett

Physics Department, Columbia University, 538 West 120th Street, New York, New York 10027, USA and Abdus Salam International Center for Theoretical Physics, Strada Costiera 11, 34151 Trieste, Italy and Physics Department, Princeton University, Princeton, New Jersey 08544, USA and INFN, Sezione di Trieste, Strada Costiera 11, 34151 Trieste, Italy.

Published: July 2014

Statistical analysis of the eigenfunctions of the Anderson tight-binding model with on-site disorder on regular random graphs strongly suggests that the extended states are multifractal at any finite disorder. The spectrum of fractal dimensions f(α) defined in Eq. (3) remains positive for α noticeably far from 1 even when the disorder is several times weaker than the one which leads to the Anderson localization; i.e., the ergodicity can be reached only in the absence of disorder. The one-particle multifractality on the Bethe lattice signals on a possible inapplicability of the equipartition law to a generic many-body quantum system as long as it remains isolated.

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevLett.113.046806DOI Listing

Publication Analysis

Top Keywords

anderson localization
8
bethe lattice
8
extended states
8
localization bethe
4
lattice nonergodicity
4
nonergodicity extended
4
states statistical
4
statistical analysis
4
analysis eigenfunctions
4
eigenfunctions anderson
4

Similar Publications

Background: While detection of circulating tumor DNA (ctDNA) weeks after surgery is linked to recurrence for other solid tumors, the optimal time point for ctDNA assessment as a prognostic biomarker following chemoradiation for anal cancer is undefined.

Methods: Patients with stages I-III anal cancer treated with chemoradiation between 12/2020-5/2024 were evaluated for HPV ctDNA status at baseline, at the end of chemoradiation, and during surveillance using a droplet digital HPV ctDNA PCR assay targeting HPV E6 and E7 oncogenes for 13 oncogenic HPV types. Median recurrence-free survival (RFS) according to HPV ctDNA status was estimated via Kaplan-Meier and compared using a log-rank test.

View Article and Find Full Text PDF

Nuclear Magnetic Resonance Study of Monoclonal Antibodies Near an Oil-Water Interface.

J Pharm Sci

January 2025

Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, FL, USA, 32310; Center for Interdisciplinary Magnetic Resonance, National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL, USA, 32310. Electronic address:

Monoclonal antibodies (mAb) represent an important class of biologic therapeutics that can treat a variety of diseases including cancer, autoimmune disorders or respiratory conditions (e.g. COVID-19).

View Article and Find Full Text PDF

A 65-year-old patient presented with recurrent, locally advanced poorly differentiated thyroid cancer despite 2 neck surgeries, and with newly diagnosed brain and skull base metastases. He was treated with palliative stereotactic radiosurgery to the brain and skull base lesions. Thereafter, as no targetable genetic alteration was identified and antiangiogenic multikinase inhibitors were deemed at high risk of hemorrhagic complications, off-label systemic therapies were considered.

View Article and Find Full Text PDF

Trans-active response DNA-binding protein-43 (TDP-43) is the major pathological protein in motor neuron disease and TDP-43 pathology has been described in the brains of up to 50% of patients with Alzheimer disease (AD). Hippocampal sclerosis of aging (HS-A), an age-related neuropathology characterized by severe neuronal loss and gliosis in CA1 and/or subiculum, is found in ∼80% of cases that are positive for phosphorylated TDP-43. HS-A is seen as a co-pathology in cases with AD, limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes (LATE-NC), and frontotemporal degeneration.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!